PATENT CLAIM ANALYSIS

Application Number: 16140914
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "167000"]

Abstract:
The technology described herein is directed to the diagnosis, prognosis, and treatment of kidney fibrosis, e.g., chronic kidney disease.

Claim (Index 4):
The method of  claim 1 , wherein the at least one gene is selected from the group consisting of:\n Cdh11; Gabrp; Mgp; Pld4; Smoc2; Mrc1; Sytl2; Stra6; Scn7a; Sema3d; Pdpn; and Pltp.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15124450', '14896168', '11329453', '15625399', '13566138']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7924889410277953
- 35 USC 102 Novelty (BERT): 0.6912659255654717
- Combined Prediction Score: 0.782366639481563
- Mean Citation Score: 368.293234
- Max Citation Score: 818.19855
- Similarity Product: 681.44435092569

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test